Group One Trading’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Group One Trading’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-330	Closed	-$20K	–	5582
2018 Q3	$20K	Sell	330 -1,760	-84%	-$119K	﹤0.01%	4389
2018 Q2	$154K	Buy	2,090 +860	+70%	+$67K	﹤0.01%	3257
2018 Q1	$81K	Sell	1,230 -30	-2%	-$2.27K	﹤0.01%	3378
2017 Q4	$106K	Sell	1,260 -1,050	-45%	-$103K	﹤0.01%	3326
2017 Q3	$267K	Buy	2,310 +1,070	+86%	+$113K	﹤0.01%	2555
2017 Q2	$145K	Buy	1,240 +340	+38%	+$42.2K	﹤0.01%	2874
2017 Q1	$111K	Buy	+900	New	+$118K	﹤0.01%	2908

Other funds holding BLCM

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Group One Trading's BLCM Position: Q2 2023 in Review

Group One Trading sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 1,066 shares — an estimated $352 sold.

Group One Trading first reported a position in BLCM in Q2 2015 and held it in 27 quarters. The position peaked at $215K in Q3 2017. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

Group One Trading reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 1,066 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $352.
Group One Trading first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 27 quarters.
Group One Trading's Bellicum Pharmaceuticals, Inc. position peaked at $215K in Q3 2017.
4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.